ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target

ROR1 and ROR2 are receptor tyrosine kinases with altered expression in a range of cancers. Silencing ROR1 or ROR2 in different tumour types has been shown to inhibit proliferation and decrease metastatic potential. The aim of this study was to investigate the role of ROR1 and ROR2 in endometrial can...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dongli, Gunther, Kate, Enriquez, Luis A., Daniels, Benjamin, O’Mara, Tracy A., Tang, Katrina, Spurdle, Amanda B., Ford, Caroline E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431863/
https://www.ncbi.nlm.nih.gov/pubmed/32807831
http://dx.doi.org/10.1038/s41598-020-70924-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431863/
https://www.ncbi.nlm.nih.gov/pubmed/32807831
http://dx.doi.org/10.1038/s41598-020-70924-z

Ejemplares similares